logo
Select company
Select metric
-202.14%EBIT Margin
VS
Market
10
Sector
33
Industry
58
History
80
$ 10.53Close
$ 5.97 - $ 67 52-Week Range
Ticker Information

Ticker

MRSN

Company Name

MERSANA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

MERSANA THERAPEUTICS INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

MRSN - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ -70.28M-202.14%$ 34.77M
3/31/2025$ -69.94M-205.68%$ 34.01M
12/31/2024$ -64.9M-160.26%$ 40.5M
9/30/2024$ -70.18M-201.46%$ 34.84M
6/30/2024$ -100.72M-336.45%$ 29.94M
3/31/2024$ -130.72M-341.33%$ 38.3M
12/31/2023$ -167.6M-454.75%$ 36.85M
9/30/2023$ -193.06M-472.7%$ 40.84M
6/30/2023$ -211.35M-545.89%$ 38.72M
3/31/2023$ -209.53M-647.76%$ 32.35M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • MERSANA THERAPEUTICS INC's latest trailing twelve months (TTM) EBIT % stands at -8731.63%.
  • Over the past 5 years, MERSANA THERAPEUTICS INC's average EBIT % has been -53494.75%.
  • The median EBIT % for MERSANA THERAPEUTICS INC during this period was -701.75%
  • MERSANA THERAPEUTICS INC reached its highest EBIT % over the past 5 years at -160.26%.
  • The lowest EBIT % recorded by MERSANA THERAPEUTICS INC in the same timeframe -392541.86%

MERSANA THERAPEUTICS INC's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
XFOR : X4 PHARMACEUTICALS INC -282.18%GBIO : GENERATION BIO CO -341.12%XLO : XILIO THERAPEUTICS INC -374.79%SNYR : SYNERGY CHC CORP 25.71%CCEL : CRYO CELL INTERNATIONAL INC 11.91%ICCC : IMMUCELL CORP 6.27%CAMP : CAMP4 THERAPEUTICS CORP -1722.08%IGC : IGC PHARMA INC -477.92%DYAI : DYADIC INTERNATIONAL INC -123.19%RVP : RETRACTABLE TECHNOLOGIES INC -21.95%

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for MERSANA THERAPEUTICS INC is calculated as follows: EBIT [ $ -75.09M ] / Revenues [ $ 860K ]
(=) EBIT % [ -8731.63% ]

MRSN - EBIT Margin, Last 5 years

-392541.86%

Minimum

Dec 31, 2021

-160.26%

Maximum

Dec 31, 2024

-53494.75%

Average

-701.75%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.54% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.54%
median9.01%
std23.96%